Safety and long-term effect of the probiotic FK-23 in patients with hepatitis C virus infection
暂无分享,去创建一个
Win Maw Tun | T. Shimada | S. Okada | A. Lwin | Y. Y. Kyaw | Kazutake Fukada | K. Oo | Akiko Goshima
[1] Y. Naito,et al. Beneficial effects of heat-treated Enterococcus faecalis FK-23 on high-fat diet-induced hepatic steatosis in mice , 2014, British Journal of Nutrition.
[2] S. Alavian,et al. Probiotic as a Novel Treatment Strategy Against Liver Disease , 2013, Hepatitis monthly.
[3] K. Shimono,et al. Prevalence and factors associated with hepatitis C virus infection among Myanmar blood donors. , 2010, Acta medica Okayama.
[4] M. Kremer,et al. Contribution of Gut Bacteria to Liver Pathobiology , 2010, Gastroenterology research and practice.
[5] M. Liong,et al. Cholesterol-Lowering Effects of Probiotics and Prebiotics: A Review of in Vivo and in Vitro Findings , 2010, International journal of molecular sciences.
[6] H. El‐Nezami,et al. Probiotics and gut health: a special focus on liver diseases. , 2010, World journal of gastroenterology.
[7] R.. Probiotics in man and animals , 2008 .
[8] T. Shimada,et al. Effect of lysed Enterococcus faecalis FK-23 on allergen-induced immune responses and intestinal microflora in antibiotic-treated weaning mice. , 2007, Journal of investigational allergology & clinical immunology.
[9] R. Korpela,et al. Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. , 2005, American journal of hypertension.
[10] C. Huber,et al. Immmunotherapy of cancer: from vision to standard clinical practice , 2004, Journal of Cancer Research and Clinical Oncology.
[11] K. Madsen,et al. Probiotics and prebiotics in gastrointestinal disorders , 2004, Current opinion in gastroenterology.
[12] T. Shirakawa,et al. Lysed enterococcus faecalis FK-23 oral administration reveals inverse association between tuberculin responses and clinical manifestations in perennial allergic rhinitis: a pilot study. , 2004, Journal of investigational allergology & clinical immunology.
[13] E. Zafrani. Non-alcoholic fatty liver disease: an emerging pathological spectrum , 2003, Virchows Archiv.
[14] A. Kanodia,et al. Biological response modifiers in cancer therapy. , 2002, The National medical journal of India.
[15] Y. Koga,et al. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. , 2001, The Journal of antimicrobial chemotherapy.
[16] W. D. de Vos,et al. Demonstration of safety of probiotics -- a review. , 1998, International journal of food microbiology.
[17] S. D. Lee,et al. Prognostic value of plasma endotoxin levels in patients with cirrhosis. , 1997, Scandinavian journal of gastroenterology.
[18] M. Saxelin,et al. Lactic Acid Bacteria in the Treatment of Acute Rotavirus Gastroenteritis , 1995, Journal of pediatric gastroenterology and nutrition.
[19] T. Yokokura,et al. Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice. , 1994, International journal of immunopharmacology.